Mortality in Peripheral Arterial Disease: A Comparison of Patients Managed by Vascular Specialists and General Practitioners
Open Access
- 13 March 2007
- journal article
- research article
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 22 (5) , 639-644
Abstract
Peripheral arterial disease (PAD) is undertreated by general practitioners (GPs). However, the impact of the suboptimal clinical management is unknown. To assess the mortality rate of PAD patients in relation to the type of physician who provides their care (GP or vascular specialist). Prospective study. Primary care practice and academic vascular laboratory. GP patients (n = 60) were those of the Peripheral Arteriopathy and Cardiovascular Events study (PACE). Patients managed by specialists (n = 82) were consecutive subjects with established PAD who were referred to our vascular laboratory during the enrolment period of the PACE study. All-cause and cardiovascular mortality. After 32 months of follow-up, specialist management was associated with a lower rate of all-cause mortality (RR = 0.04; 95% CI 0.01–0.34; p = .003) and cardiovascular mortality (RR = 0.07; 95% CI 0.01–0.65; p = .020), after adjustment for patients’ characteristics. Specialists were more likely to use antiplatelet agents (93% vs 73%, p < .001), statins (62% vs 25%, p < .001) and beta blockers (28% vs 3%, p < .001). Survival differences between specialists and GPs disappeared once the use of pharmacotherapies was added to the proportional hazard model. The fully adjusted model showed that the use of statins was significantly associated with a reduced risk of all-cause mortality (RR = 0.02; 95% CI 0.01–0.73, p = .034) and cardiovascular mortality (RR = 0.02; 95% CI 0.01–0.71, p = .033). Specialist management of patients with symptomatic PAD resulted in better survival than generalist management. This effect appears to be mainly caused by the more frequent use of effective medicines by specialists.Keywords
This publication has 31 references indexed in Scilit:
- Statin therapy improves cardiovascular outcome of patients with peripheral artery diseaseEuropean Heart Journal, 2004
- Risk of Myocardial Infarction and Angina in Patients With Severe Peripheral Vascular DiseaseCirculation, 2002
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Atherosclerotic Risk Factors Are Less Intensively Treated in Patients with Peripheral Arterial Disease Than in Patients with Coronary Artery DiseaseJournal of General Internal Medicine, 1997
- Incidence, Natural History and Cardiovascular Events in Symptomatic and Asymptomatic Peripheral Arterial Disease in the General PopulationInternational Journal of Epidemiology, 1996
- Prediction of late cardiac events by dipyridamole thallium scintigraphy in patients with intermittent claudication and occult coronary artery diseaseThe American Journal of Cardiology, 1996
- The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT InvestigatorsJAMA, 1996
- Reducing Bias in Observational Studies Using Subclassification on the Propensity ScoreJournal of the American Statistical Association, 1984
- The central role of the propensity score in observational studies for causal effectsBiometrika, 1983
- Quantitative ultrasonographic studies of lower extremity flow velocities in health and disease.Circulation, 1976